Research Article
Preparation, Characterization, and Preliminary Imaging Study of [188Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis
Figure 5
Weight change of mice injected with normal saline or different doses of [188Re]Re-IBA within 4 weeks.